Resistance to inhibitors of cholinesterase 3 (Ric-3) expression promotes selective protein associations with the human α7-nicotinic acetylcholine receptor interactome

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Mulcahy, Matthew J ^a   Blattman, Sydney B ^a   Barrantes, Francisco J ^b   Lukas, Ronald J ^c   Hawrot, Edward ^a  

^a BROWN UNIVERSITY   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; CHOLINESTERASE; CYCLIC AMP; INOSITOL TRISPHOSPHATE; RESISTANCE TO INHIBITORS OF CHOLINESTERASE 3; UNCLASSIFIED DRUG; BUNGAROTOXIN; CHAPERONE; CHOLINESTERASE INHIBITOR; CHRNA7 PROTEIN, HUMAN; PROTEIN BINDING; RIC3 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; BIOGENESIS; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; APOPTOSIS; CELL MEMBRANE; CHEMISTRY; ENDOPLASMIC RETICULUM; GENETICS; GOLGI COMPLEX; LIQUID CHROMATOGRAPHY; METABOLISM; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; APOPTOSIS; BUNGAROTOXINS; CELL LINE, TUMOR; CELL MEMBRANE; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, LIQUID; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MASS SPECTROMETRY; MOLECULAR CHAPERONES; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84942436787     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134409     Document Type: Article

References (107)

1. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual review of pharmacology and toxicology. 2007; 47:699-729. doi: 10. 1146/annurev.pharmtox.47.120505.105214 PMID: 17009926.
2. Peng X, Katz M, Gerzanich V, Anand R, Lindstrom J. Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol Pharmacol. 1994; 45(3):546-54. PMID: 8145738.
3. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009; 89(1):73-120. doi: 10.1152/physrev.00015.2008 PMID: 19126755; PubMed Central PMCID: PMC2713585.
4. Shen JX, Yakel JL. Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacol Sin. 2009; 30(6):673-80. doi: 10.1038/aps.2009.64 PMID: 19448647; PubMed Central PMCID: PMC4002362.
5. Araud T, Wonnacott S, Bertrand D. Associated proteins: The universal toolbox controlling ligand gated ion channel function. Biochem Pharmacol. 2010; 80(2):160-9. doi: 10.1016/j.bcp.2010.03.017 PMID: 20346921.
6. St John PA. Cellular trafficking of nicotinic acetylcholine receptors. Acta Pharmacol Sin. 2009; 30 (6):656-62. doi: 10.1038/aps.2009.76 PMID: 19498414; PubMed Central PMCID: PMC4002369.
7. Colombo SF, Mazzo F, Pistillo F, Gotti C. Biogenesis, trafficking and up-regulation of nicotinic ACh receptors. Biochem Pharmacol. 2013; 86(8):1063-73. doi: 10.1016/j.bcp.2013.06.023 PMID: 23830821.
8. Castillo M, Mulet J, Gutierrez LM, Ortiz JA, Castelan F, Gerber S, et al. Dual role of the RIC-3 protein in trafficking of serotonin and nicotinic acetylcholine receptors. The Journal of biological chemistry. 2005; 280(29):27062-8. doi: 10.1074/jbc.M503746200 PMID: 15927954.
9. Vallés AS, Roccamo AM, Barrantes FJ. Ric-3 chaperone-mediated stable cell-surface expression of the neuronal alpha7 nicotinic acetylcholine receptor in mammalian cells. Acta pharmacologica sinica. 2009; 30(6):818-27. doi: 10.1038/aps.2009.54 PMID: 19498422
10. Wanamaker CP, Christianson JC, Green WN. Regulation of nicotinic acetylcholine receptor assembly. Annals of the New York Academy of Sciences. 2003; 998:66-80. PMID: 14592864.
11. Banerjee C, Nyengaard JR, Wevers A, de Vos RA, Jansen Steur EN, Lindstrom J, et al. Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease - a stereological approach. Neurobiology of disease. 2000; 7(6 Pt B):666-72. doi: 10.1006/nbdi.2000.0317 PMID: 11114264.
12. Wevers A, Burghaus L, Moser N, Witter B, Steinlein OK, Schutz U, et al. Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches. Behavioural brain research. 2000; 113(1-2):207-15. PMID: 10942047.
13. Yu WF, Guan ZZ, Bogdanovic N, Nordberg A. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Experimental neurology. 2005; 192(1):215-25. doi: 10.1016/j.expneurol.2004.12.015 PMID: 15698636.
14. Counts SE, He B, Che S, Ikonomovic MD, DeKosky ST, Ginsberg SD, et al. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Archives of neurology. 2007; 64(12):1771-6. doi: 10.1001/archneur.64.12.1771 PMID: 18071042.
15. Ikonomovic MD, Wecker L, Abrahamson EE, Wuu J, Counts SE, Ginsberg SD, et al. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease. Archives of neurology. 2009; 66(5):646-51. doi: 10.1001/archneurol.2009.46 PMID: 19433665; PubMed Central PMCID: PMC2841566.
16. Matsumura A, Suzuki S, Iwahara N, Hisahara S, Kawamata J, Suzuki H, et al. Temporal Changes of CD68 and alpha7 Nicotinic Acetylcholine Receptor Expression in Microglia in Alzheimer's Disease-Like Mouse Models. Journal of Alzheimer's disease: JAD. 2014. doi: 10.3233/JAD-141572 PMID: 25352454.
17. Wanamaker CP, Green WN. Endoplasmic reticulum chaperones stabilize nicotinic receptor subunits and regulate receptor assembly. The Journal of biological chemistry. 2007; 282(43):31113-23. doi: 10.1074/jbc.M705369200 PMID: 17728248; PubMed Central PMCID: PMC2365492.
18. Wang Y, Yao Y, Tang XQ, Wang ZZ. Mouse RIC-3, an endoplasmic reticulum chaperone, promotes assembly of the alpha7 acetylcholine receptor through a cytoplasmic coiled-coil domain. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2009; 29(40):12625-35. doi: 10. 1523/JNEUROSCI.1776-09.2009 PMID: 19812337; PubMed Central PMCID: PMC3849731.
19. Halevi S, McKay J, Palfreyman M, Yassin L, Eshel M, Jorgensen E, et al. The C. elegans ric-3 gene is required for maturation of nicotinic acetylcholine receptors. The EMBO journal. 2002; 21(5):1012-20. doi: 10.1093/emboj/21.5.1012 PMID: 11867529; PubMed Central PMCID: PMC125878.
20. Cheng A, Bollan KA, Greenwood SM, Irving AJ, Connolly CN. Differential subcellular localization of RIC-3 isoforms and their role in determining 5-HT3 receptor composition. The Journal of biological chemistry. 2007; 282(36):26158-66. doi: 10.1074/jbc.M703899200 PMID: 17609200.
21. Millar NS. RIC-3: a nicotinic acetylcholine receptor chaperone. British journal of pharmacology. 2008; 153 Suppl 1:S177-83. doi: 10.1038/sj.bjp.0707661 PMID: 18246096; PubMed Central PMCID: PMC2268041.
22. Walstab J, Hammer C, Lasitschka F, Moller D, Connolly CN, Rappold G, et al. RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A,-C,-D, and-E subunits. The Journal of biological chemistry. 2010; 285(35):26956-65. doi: 10.1074/jbc.M110.122838 PMID: 20522555; PubMed Central PMCID: PMC2930695.
23. Lansdell SJ, Gee VJ, Harkness PC, Doward AI, Baker ER, Gibb AJ, et al. RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells. Molecular pharmacology. 2005; 68(5):1431-8. doi: 10.1124/mol.105.017459 PMID: 16120769.
24. Valles AS, Barrantes FJ. Chaperoning alpha7 neuronal nicotinic acetylcholine receptors. Biochimica et biophysica acta. 2012; 1818(3):718-29. doi: 10.1016/j.bbamem.2011.10.012 PMID: 22040696.
25. Castelan F, Castillo M, Mulet J, Sala S, Sala F, del Toro ED, et al. Molecular characterization and localization of the RIC-3 protein, an effector of nicotinic acetylcholine receptor expression. Journal of Neurochemistry. 2008; 105(3):617-27. doi: 10.1111/j.1471-4159.2007.05169.x WOS:000255139200005. PMID: 18179477
26. Koperniak TM, Garg BK, Boltax J, Loring RH. Cell-specific effects on surface alpha7 nicotinic receptor expression revealed by over-expression and knockdown of rat RIC3 protein. J Neurochem. 2013; 124 (3):300-9. doi: 10.1111/jnc.12095 PMID: 23157401.
27. Lukas RJ, Norman SA, Lucero L. Characterization of Nicotinic Acetylcholine Receptors Expressed by Cells of the SH-SY5Y Human Neuroblastoma Clonal Line. Molecular and cellular neurosciences. 1993; 4(1):1-12. doi: 10.1006/mcne.1993.1001 PMID: 19912902.
28. Peng JH, Fryer JD, Hurst RS, Schroeder KM, George AA, Morrissy S, et al. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells. J Pharmacol Exp Ther. 2005; 313(1):24-35. doi: 10. 1124/jpet.104.079004 PMID: 15590768.
29. Paulo JA, Brucker WJ, Hawrot E. Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome. Journal of proteome research. 2009; 8(4):1849-58. doi: 10.1021/pr800731z PMID: 19714875; PubMed Central PMCID: PMC2891571.
30. Wu J, Kuo YP, George AA, Xu L, Hu J, Lukas RJ. beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells. The Journal of biological chemistry. 2004; 279(36):37842-51. doi: 10.1074/jbc.M400335200 PMID: 15234980.
31. Simonson PD, Deberg HA, Ge P, Alexander JK, Jeyifous O, Green WN, et al. Counting bungarotoxin binding sites of nicotinic acetylcholine receptors in mammalian cells with high signal/noise ratios. Biophysical journal. 2010; 99(10):L81-3. doi: 10.1016/j.bpj.2010.08.076 PMID: 21081055; PubMed Central PMCID: PMC2980733.
32. Kessner D, Chambers M, Burke R, Agus D, Mallick P. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics. 2008; 24(21):2534-6. doi: 10.1093/bioinformatics/btn323 PMID: 18606607; PubMed Central PMCID: PMC2732273.
33. Keller A NA, Kolker E, Aebersold R. Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database Search. Analytical Chemistry. 2002; 74:5383-92. PMID: 12403597
34. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem. 2003; 75(17):4646-58. PMID: 14632076.
35. Weatherly DB, Atwood JA 3rd, Minning TA, Cavola C, Tarleton RL, Orlando R. A Heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results. Molecular & cellular proteomics: MCP. 2005; 4(6):762-72. doi: 10.1074/mcp.M400215-MCP200 PMID: 15703444.
36. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2009; 4(1):44-57. doi: 10.1038/nprot.2008.211 PMID: 19131956.
37. Mi H, Muruganujan A, Casagrande JT, Thomas PD. Large-scale gene function analysis with the PANTHER classification system. Nature protocols. 2013; 8(8):1551-66. doi: 10.1038/nprot.2013.092 PMID: 23868073.
38. Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic acids research. 2013; 41(Database issue):D377-86. doi: 10.1093/nar/gks1118 PMID: 23193289; PubMed Central PMCID: PMC3531194.
39. Williams ME, Burton B, Urrutia A, Shcherbatko A, Chavez-Noriega LE, Cohen CJ, et al. Ric-3 promotes functional expression of the nicotinic acetylcholine receptor alpha7 subunit in mammalian cells. The Journal of biological chemistry. 2005; 280(2):1257-63. doi: 10.1074/jbc.M410039200 PMID: 15504725.
40. Nyathi Y, Wilkinson BM, Pool MR. Co-translational targeting and translocation of proteins to the endoplasmic reticulum. Biochimica et biophysica acta. 2013; 1833(11):2392-402. doi: 10.1016/j.bbamcr. 2013.02.021 PMID: 23481039.
41. Sommer N, Junne T, Kalies KU, Spiess M, Hartmann E. TRAP assists membrane protein topogenesis at the mammalian ER membrane. Biochimica et biophysica acta. 2013; 1833(12):3104-11. doi: 10. 1016/j.bbamcr.2013.08.018 PMID: 24013069.
42. Maeda Y, Kinoshita T. Dolichol-phosphate mannose synthase: structure, function and regulation. Biochimica et biophysica acta. 2008; 1780(6):861-8. doi: 10.1016/j.bbagen.2008.03.005 PMID: 18387370.
43. Wanamaker CP, Green WN. N-linked glycosylation is required for nicotinic receptor assembly but not for subunit associations with calnexin. The Journal of biological chemistry. 2005; 280(40):33800-10. doi: 10.1074/jbc.M501813200 PMID: 16091366; PubMed Central PMCID: PMC2373277.
44. Nicke A, Thurau H, Sadtler S, Rettinger J, Schmalzing G. Assembly of nicotinic alpha7 subunits in Xenopus oocytes is partially blocked at the tetramer level. FEBS letters. 2004; 575(1-3):52-8. doi: 10.1016/j.febslet.2004.08.035 PMID: 15388332.
45. Benham AM. Protein secretion and the endoplasmic reticulum. Cold Spring Harb Perspect Biol. 2012; 4(8):a012872. doi: 10.1101/cshperspect.a012872 PMID: 22700933; PubMed Central PMCID: PMC3405867.
46. Keller SH, Lindstrom J, Taylor P. Inhibition of glucose trimming with castanospermine reduces calnexin association and promotes proteasome degradation of the alpha-subunit of the nicotinic acetylcholine receptor. The Journal of biological chemistry. 1998; 273(27):17064-72. PMID: 9642271.
47. Gelebart P, Opas M, Michalak M. Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum. The international journal of biochemistry & cell biology. 2005; 37(2):260-6. doi: 10.1016/j.biocel. 2004.02.030 PMID: 15474971.
48. Wanamaker CP, Green WN. Endoplasmic Reticulum Chaperones Stabilize Nicotinic Receptor Subunits and Regulate Receptor Assembly. The Journal of Biological Chemistry. 2007; 282:31113-23. PMID: 17728248
49. Helekar SA, Char D, Neff S, Patrick J. Prolyl isomerase requirement for the expression of functional homo-oligomeric ligand-gated ion channels. Neuron. 1994; 12(1):179-89. PMID: 7507339.
50. Forsayeth JR, Gu Y, Hall ZW. BiP forms stable complexes with unassembled subunits of the acetylcholine receptor in transfected COS cells and in C2 muscle cells. The Journal of cell biology. 1992; 117(4):841-7. PMID: 1577860; PubMed Central PMCID: PMC2289465.
51. Paulson HL, Ross AF, Green WN, Claudio T. Analysis of early events in acetylcholine receptor assembly. The Journal of cell biology. 1991; 113(6):1371-84. PMID: 2045417; PubMed Central PMCID: PMC2289024.
52. Blount P, Merlie JP. BIP associates with newly synthesized subunits of the mouse muscle nicotinic receptor. The Journal of cell biology. 1991; 113(5):1125-32. PMID: 2040645; PubMed Central PMCID: PMC2289008.
53. Meunier L, Usherwood YK, Chung KT, Hendershot LM. A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Molecular biology of the cell. 2002; 13(12):4456-69. doi: 10.1091/mbc.E02-05-0311 PMID: 12475965; PubMed Central PMCID: PMC138646.
54. Yebenes H, Mesa P, Munoz IG, Montoya G, Valpuesta JM. Chaperonins: two rings for folding. Trends Biochem Sci. 2011; 36(8):424-32. doi: 10.1016/j.tibs.2011.05.003 PMID: 21723731.
55. Yam AY, Xia Y, Lin HT, Burlingame A, Gerstein M, Frydman J. Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologies. Nature structural & molecular biology. 2008; 15(12):1255-62. doi: 10.1038/nsmb.1515 PMID: 19011634; PubMed Central PMCID: PMC2658641.
56. Tsuji A, Kikuchi Y, Sato Y, Koide S, Yuasa K, Nagahama M, et al. A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4. The Biochemical journal. 2006; 396(1):51-9. PMID: 16433634; PubMed Central PMCID: PMC1449992.
57. Honore B. The rapidly expanding CREC protein family: members, localization, function, and role in disease. BioEssays: news and reviews in molecular, cellular and developmental biology. 2009; 31 (3):262-77. doi: 10.1002/bies.200800186 PMID: 19260022.
58. Sahlender DA, Roberts RC, Arden SD, Spudich G, Taylor MJ, Luzio JP, et al. Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. The Journal of cell biology. 2005; 169(2):285-95. doi: 10.1083/jcb.200501162 PMID: 15837803; PubMed Central PMCID: PMC2171882.
59. Cho CH, Song W, Leitzell K, Teo E, Meleth AD, Quick MW, et al. Rapid upregulation of alpha7 nicotinic acetylcholine receptors by tyrosine dephosphorylation. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2005; 25(14):3712-23. doi: 10.1523/JNEUROSCI.5389-03. 2005 PMID: 15814802.
60. Green WN, Ross AF, Claudio T. Acetylcholine receptor assembly is stimulated by phosphorylation of its gamma subunit. Neuron. 1991; 7(4):659-66. PMID: 1931053.
61. Charpantier E, Wiesner A, Huh KH, Ogier R, Hoda JC, Allaman G, et al. Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2005; 25(43):9836-49. doi: 10.1523/JNEUROSCI.3497-05.2005 PMID: 16251431.
62. Sava A, Barisone I, Di Mauro D, Fumagalli G, Sala C. Modulation of nicotinic acetylcholine receptor turnover by tyrosine phosphorylation in rat myotubes. Neuroscience letters. 2001; 313(1-2):37-40. PMID: 11684334.
63. De Koninck P, Cooper E. Differential regulation of neuronal nicotinic ACh receptor subunit genes in cultured neonatal rat sympathetic neurons: specific induction of alpha 7 by membrane depolarization through a Ca2+/calmodulin-dependent kinase pathway. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1995; 15(12):7966-78. PMID: 8613734.
64. Jeanclos EM, Lin L, Treuil MW, Rao J, DeCoster MA, Anand R. The chaperone protein 14-3-3eta interacts with the nicotinic acetylcholine receptor alpha 4 subunit. Evidence for a dynamic role in subunit stabilization. The Journal of biological chemistry. 2001; 276(30):28281-90. doi: 10.1074/jbc. M011549200 PMID: 11352901.
65. Francis SH, Corbin JD. Structure and function of cyclic nucleotide-dependent protein kinases. Annual review of physiology. 1994; 56:237-72. doi: 10.1146/annurev.ph.56.030194.001321 PMID: 8010741.
66. Mucignat-Caretta C. Aggregates of cAMP-dependent kinase RIalpha characterize a type of cholinergic neurons in the rat brain. Brain research Molecular brain research. 2000; 80(2):233-6. PMID: 11038256.
67. Dajas-Bailador FA, Soliakov L, Wonnacott S. Nicotine activates the extracellular signal-regulated kinase 1/2 via the alpha7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones. J Neurochem. 2002; 80(3):520-30. PMID: 11905997.
68. Welsby PJ, Rowan MJ, Anwyl R. Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus. The European journal of neuroscience. 2009; 29(1):65-75. doi: 10.1111/j.1460-9568.2008.06562.x PMID: 19077124.
69. Welsby PJ, Rowan MJ, Anwyl R. Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTP. Neuropharmacology. 2007; 53(1):188-95. doi: 10.1016/j.neuropharm.2007. 05.013 PMID: 17610911.
70. Medeiros R, Castello NA, Cheng D, Kitazawa M, Baglietto-Vargas D, Green KN, et al. alpha7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles. The American journal of pathology. 2014; 184(2):520-9. doi: 10.1016/j.ajpath.2013.10.010 PMID: 24269557.
71. Wojcik S. Crosstalk between autophagy and proteasome protein degradation systems: possible implications for cancer therapy. Folia histochemica et cytobiologica/Polish Academy of Sciences, Polish Histochemical and Cytochemical Society. 2013; 51(4):249-64. doi: 10.5603/FHC.2013.0036 PMID: 24497130.
72. Verstrepen L, Verhelst K, Carpentier I, Beyaert R. TAX1BP1, a ubiquitin-binding adaptor protein in innate immunity and beyond. Trends Biochem Sci. 2011; 36(7):347-54. doi: 10.1016/j.tibs.2011.03. 004 PMID: 21546252.
73. Chang TK, Shravage BV, Hayes SD, Powers CM, Simin RT, Wade Harper J, et al. Uba1 functions in Atg7-and Atg3-independent autophagy. Nature cell biology. 2013; 15(9):1067-78. doi: 10.1038/ncb2804 PMID: 23873149; PubMed Central PMCID: PMC3762904.
74. Tamura H, Shibata M, Koike M, Sasaki M, Uchiyama Y. Atg9A protein, an autophagy-related membrane protein, is localized in the neurons of mouse brains. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 2010; 58(5):443-53. doi: 10.1369/jhc.2010. 955690 PMID: 20124090; PubMed Central PMCID: PMC2857816.
75. Orsi A, Razi M, Dooley HC, Robinson D, Weston AE, Collinson LM, et al. Dynamic and transient interactions of Atg9 with autophagosomes, but not membrane integration, are required for autophagy. Molecular biology of the cell. 2012; 23(10):1860-73. doi: 10.1091/mbc.E11-09-0746 PMID: 22456507; PubMed Central PMCID: PMC3350551.
76. Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 2014; 509(7498):105-9. doi: 10. 1038/nature13148 PMID: 24695223; PubMed Central PMCID: PMC4180099.
77. Cenciarelli C, Chiaur DS, Guardavaccaro D, Parks W, Vidal M, Pagano M. Identification of a family of human F-box proteins. Current biology: CB. 1999; 9(20):1177-9. doi: 10.1016/S0960-9822(00) 80020-2 PMID: 10531035.
78. Newman AC, Scholefield CL, Kemp AJ, Newman M, McIver EG, Kamal A, et al. TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-kappaB signalling. PloS one. 2012; 7(11):e50672. doi: 10.1371/journal.pone.0050672 PMID: 23209807; PubMed Central PMCID: PMC3510188.
79. Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nature communications. 2014; 5:3496. doi: 10.1038/ncomms4496 PMID: 24667209; PubMed Central PMCID: PMC3990284.
80. Into T, Inomata M, Takayama E, Takigawa T. Autophagy in regulation of Toll-like receptor signaling. Cellular signalling. 2012; 24(6):1150-62. doi: 10.1016/j.cellsig.2012.01.020 PMID: 22333395.
81. Wang D, Liang J, Zhang Y, Gui B, Wang F, Yi X, et al. Steroid receptor coactivator-interacting protein (SIP) inhibits caspase-independent apoptosis by preventing apoptosis-inducing factor (AIF) from being released from mitochondria. The Journal of biological chemistry. 2012; 287(16):12612-21. doi: 10.1074/jbc.M111.334151 PMID: 22371500; PubMed Central PMCID: PMC3339961.
82. Suzuki T, Hide I, Matsubara A, Hama C, Harada K, Miyano K, et al. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. Journal of neuroscience research. 2006; 83(8):1461-70. doi: 10.1002/jnr.20850 PMID: 16652343.
83. Zhong C, Talmage DA, Role LW. Nicotine elicits prolonged calcium signaling along ventral hippocampal axons. PloS one. 2013; 8(12):e82719. doi: 10.1371/journal.pone.0082719 PMID: 24349346; PubMed Central PMCID: PMC3857818.
84. Mizuno K, Kurokawa K, Ohkuma S. Nicotinic acetylcholine receptors regulate type 1 inositol 1,4,5-trisphosphate receptor expression via calmodulin kinase IV activation. Journal of neuroscience research. 2015; 93(4):660-5. doi: 10.1002/jnr.23518 PMID: 25430056.
85. Nordman JC, Kabbani N. Microtubule dynamics at the growth cone are mediated by alpha7 nicotinic receptor activation of a Galphaq and IP3 receptor pathway. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2014; 28(7):2995-3006. doi: 10.1096/fj. 14-251439 PMID: 24687992; PubMed Central PMCID: PMC4062821.
86. Powell JA, Molgo J, Adams DS, Colasante C, Williams A, Bohlen M, et al. IP3 receptors and associated Ca2+ signals localize to satellite cells and to components of the neuromuscular junction in skeletal muscle. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2003; 23 (23):8185-92. PMID: 12967979.
87. Thumkeo D, Watanabe S, Narumiya S. Physiological roles of Rho and Rho effectors in mammals. European journal of cell biology. 2013; 92(10-11):303-15. doi: 10.1016/j.ejcb.2013.09.002 PMID: 24183240.
88. Zhou X, Zheng Y. Cell type-specific signaling function of RhoA GTPase: lessons from mouse gene targeting. The Journal of biological chemistry. 2013; 288(51):36179-88. doi: 10.1074/jbc.R113. 515486 PMID: 24202176; PubMed Central PMCID: PMC3868732.
89. O'Connor K, Chen M. Dynamic functions of RhoA in tumor cell migration and invasion. Small GTPases. 2013; 4(3):141-7. doi: 10.4161/sgtp.25131 PMID: 24025634; PubMed Central PMCID: PMC3976970.
90. Endo M, Nakano M, Kadomatsu T, Fukuhara S, Kuroda H, Mikami S, et al. Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer research. 2012; 72(7):1784-94. doi: 10.1158/0008-5472.CAN-11-3878 PMID: 22345152.
91. Aoi J, Endo M, Kadomatsu T, Miyata K, Nakano M, Horiguchi H, et al. Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer research. 2011; 71 (24):7502-12. doi: 10.1158/0008-5472.CAN-11-1758 PMID: 22042794.
92. Odagiri H, Kadomatsu T, Endo M, Masuda T, Morioka MS, Fukuhara S, et al. The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin alpha5beta1, p38 MAPK, and matrix metalloproteinases. Science signaling. 2014; 7(309):ra7. doi: 10.1126/scisignal.2004612 PMID: 24448647.
93. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell metabolism. 2009; 10(3):178-88. doi: 10.1016/j.cmet.2009.08.003 PMID: 19723494.
94. Farhat N, Mamarbachi AM, Thorin E, Allen BG. Cloning, expression and purification of functionally active human angiopoietin-like protein 2. SpringerPlus. 2014; 3:337. doi: 10.1186/2193-1801-3-337 PMID: 25077060; PubMed Central PMCID: PMC4112196.
95. Kumari S, Borroni V, Chaudhry A, Chanda B, Massol R, Mayor S, et al. Nicotinic acetylcholine receptor is internalized via a Rac-dependent, dynamin-independent endocytic pathway. The Journal of cell biology. 2008; 181(7):1179-93. doi: 10.1083/jcb.200709086 PMID: 18591431; PubMed Central PMCID: PMC2442195.
96. Fan K, Gao L, Yan X. Human ferritin for tumor detection and therapy. Wiley interdisciplinary reviews Nanomedicine and nanobiotechnology. 2013; 5(4):287-98. doi: 10.1002/wnan.1221 PMID: 23606622.
97. Galbiati F, Volonte D, Chu JB, Li M, Fine SW, Fu M, et al. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proceedings of the National Academy of Sciences of the United States of America. 2000; 97(17):9689-94. doi: 10.1073/pnas.160249097 PMID: 10931944; PubMed Central PMCID: PMC16926.
98. Conde SV, Monteiro EC. Activation of nicotinic ACh receptors with alpha4 subunits induces adenosine release at the rat carotid body. British journal of pharmacology. 2006; 147(7):783-9. doi: 10. 1038/sj.bjp.0706676 PMID: 16444287; PubMed Central PMCID: PMC1751505.
99. Umlauf E, Mairhofer M, Prohaska R. Characterization of the stomatin domain involved in homo-oligomerization and lipid raft association. The Journal of biological chemistry. 2006; 281(33):23349-56. doi: 10.1074/jbc.M513720200 PMID: 16766530.
100. Price MP, Thompson RJ, Eshcol JO, Wemmie JA, Benson CJ. Stomatin modulates gating of acidsensing ion channels. The Journal of biological chemistry. 2004; 279(51):53886-91. doi: 10.1074/jbc. M407708200 PMID: 15471860.
101. Sarkar D, Fisher PB. AEG-1/MTDH/LYRIC: clinical significance. Advances in cancer research. 2013; 120:39-74. doi: 10.1016/B978-0-12-401676-7.00002-4 PMID: 23889987; PubMed Central PMCID: PMC3924591.
102. Yoo BK, Emdad L, Lee SG, Su ZZ, Santhekadur P, Chen D, et al. Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology. Pharmacology & therapeutics. 2011; 130(1):1-8. doi: 10.1016/j.pharmthera.2011.01.008 PMID: 21256156; PubMed Central PMCID: PMC3043119.
103. Peterfi Z, Donko A, Orient A, Sum A, Prokai A, Molnar B, et al. Peroxidasin is secreted and incorporated into the extracellular matrix of myofibroblasts and fibrotic kidney. The American journal of pathology. 2009; 175(2):725-35. doi: 10.2353/ajpath.2009.080693 PMID: 19590037; PubMed Central PMCID: PMC2716968.
104. Cheng G, Salerno JC, Cao Z, Pagano PJ, Lambeth JD. Identification and characterization of VPO1, a new animal heme-containing peroxidase. Free radical biology & medicine. 2008; 45(12):1682-94. doi: 10.1016/j.freeradbiomed.2008.09.009 PMID: 18929642; PubMed Central PMCID: PMC2659527.
105. Huebsch KA, Maimone MM. Rapsyn-mediated clustering of acetylcholine receptor subunits requires the major cytoplasmic loop of the receptor subunits. Journal of neurobiology. 2003; 54(3):486-501. doi: 10.1002/neu.10177 PMID: 12532399.
106. Arredondo J, Chernyavsky AI, Jolkovsky DL, Webber RJ, Grando SA. SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium. Journal of cellular physiology. 2006; 208 (1):238-45. doi: 10.1002/jcp.20661 PMID: 16575903.
107. Tsetlin VI. Three-finger snake neurotoxins and Ly6 proteins targeting nicotinic acetylcholine receptors: pharmacological tools and endogenous modulators. Trends in pharmacological sciences. 2015; 36(2):109-23. doi: 10.1016/j.tips.2014.11.003 PMID: 25528970.